Pixcell
Home Page

Board of Directors

Prof. Max Herzberg
Prof. Max Herzberg, Chairman. Prof. Herzberg holds a Ph.D. in molecular biology from the Weizmann Institute of Science. He founded and sold Orgenics Ltd (HIV detection kits), was the first chairman of the Israeli National Committee for Biotechnology and is a board member in numerous biotech companies around the world.
Dr. Avishay Bransky
Dr. Avishay Bransky, CEO. Dr. Bransky holds a B.A. in physics, B.Sc. in materials engineering and a Ph.D. in biomedical engineering from the Technion – Israel Institute of Technology. Dr. Bransky has a broad industrial experience in software and systems engineering from Elscint, Qualcomm and Trellis Photonics. He is also the entrepreneur of the PixCell technology, which is based on the Viscoelastic Focusing effect that he had worked on at the Technion for 5 years. Dr. Bransky was CEO of PixCell's subsidiary Hemoscreen, and successfully led it to an early graduation of the technological incubator period.
Shmuel Cabilly, PhD
Shmuel Cabilly, PhD. Shmuel is a highly regarded scientist and an experienced director. He has previously worked with several companies including co-founding and practicing as Chief Scientist in Ethrog Biotech, which was sold to Invitrogen. He graduated the Hebrew University (PhD, immunology) and was a Post-Doctoral fellow at the City of Hope Research Institute, heading a joint City of Hope / Genentech project, where he developed a new technology for recombinant antibody production.
David Herzberg
David Herzberg studied statistics and probability in Paris and made most of his carreer at J.P Morgan bank in London where he became a senior executive in charge of the global equity derivatives business. David is presently Managing Partner of Btg-Pactual  and a co-founder of H&Co a management and investment entity specializing in Biotech.
©2010 Pixcell Ltd. All Rights Reserved.